KRAS and neoplasm: In three patients (CRC152, CRC160, CRC164), tumor tissue showed variants in the same KRAS codon number as was seen in cfDNA analyzed by BEAMing and TST170; however, the specific variant identified was different between TST170 and tumor tissue (Table 2).